NIVEX TRIAL (GECP 1605): Nivolumab in the Real World: Spanish Expanded Access Program Experience in Pretreated Advanced NSCLC Patients

dc.contributor.authorRodriguez-Abreu, D.
dc.contributor.authorCampillo, J.
dc.contributor.authorGrau, F.
dc.contributor.authorCarcereny, E.
dc.contributor.authorBernabe, R.
dc.contributor.authorGarcia, Y.
dc.contributor.authorArtal Cortes, A.
dc.contributor.authorGonzalez Cao, M.
dc.contributor.authorJuan, O.
dc.contributor.authorGaricano, F.
dc.contributor.authorGil-Bazo, I.
dc.contributor.authorBlanco, R.
dc.contributor.authorGuillot, M.
dc.contributor.authorProvencio, M.
dc.contributor.authorMajem, M.
dc.contributor.authoraffiliation[Rodriguez-Abreu, D.] Hosital Insular Gran Canaria, Med Oncol, Las Palmas Gran Canaria, Spain
dc.contributor.authoraffiliation[Campillo, J.] Hosp Virgen Arrixaca, Murcia, Spain
dc.contributor.authoraffiliation[Grau, F.] Hosp Univ Hebron, Barcelona, Spain
dc.contributor.authoraffiliation[Carcereny, E.] Hosp Germans Trias I Pujol, Catalan Inst Oncol, Med Oncol, Badalona, Spain
dc.contributor.authoraffiliation[Bernabe, R.] Hosp Univ Virgen Rocio, Seville, Spain
dc.contributor.authoraffiliation[Garcia, Y.] Corp Sanitaria Parc Tauli, Sabadell, Spain
dc.contributor.authoraffiliation[Artal Cortes, A.] Hosp Univ Miguel Servet, Med Oncol, Zaragoza, Spain
dc.contributor.authoraffiliation[Gonzalez Cao, M.] Hosp Univ Dexeus, Barcelona, Spain
dc.contributor.authoraffiliation[Juan, O.] Hosp Univ La Fe, Valencia, Spain
dc.contributor.authoraffiliation[Garicano, F.] Hosp Galdakao, Galdakao, Spain
dc.contributor.authoraffiliation[Gil-Bazo, I.] Clin Univ Navarra, Pamplona, Spain
dc.contributor.authoraffiliation[Blanco, R.] Consorci Sanitari Terrassa, Terrassa, Spain
dc.contributor.authoraffiliation[Guillot, M.] Hosp Son Espases, Palma De Mallorca, Spain
dc.contributor.authoraffiliation[Provencio, M.] Hosp Puerta Hierro, Med Oncol, Madrid, Spain
dc.contributor.authoraffiliation[Majem, M.] Hosp Santa Creu I Sant Pau, Barcelona, Spain
dc.date.accessioned2025-01-07T15:34:24Z
dc.date.available2025-01-07T15:34:24Z
dc.date.issued2018-10-01
dc.identifier.doi10.1016/j.jtho.2018.08.1467
dc.identifier.essn1556-1380
dc.identifier.issn1556-0864
dc.identifier.unpaywallURLhttp://www.jto.org/article/S1556086418324250/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27248
dc.identifier.wosID454014503129
dc.issue.number10
dc.issue.numberS
dc.journal.titleJournal of thoracic oncology
dc.journal.titleabbreviationJ. thorac. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS827-S827
dc.publisherElsevier science inc
dc.rights.accessRightsopen access
dc.subjectreal world
dc.subjectnivolumab
dc.subjectNSCLC
dc.titleNIVEX TRIAL (GECP 1605): Nivolumab in the Real World: Spanish Expanded Access Program Experience in Pretreated Advanced NSCLC Patients
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number13
dc.wostypeMeeting Abstract

Files